Clonidine transdermal system 0.3 mg per 1 d patch

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Actavis Pharma, Inc. names for other drugs.

Recalls

• Mar 19, 2026 · Class II · Teva Pharmaceuticals USA, Inc
  CGMP Deviations: use of an unapproved raw material
  Lots: Lot: 100060315, Exp.: 04/2026; 100068644, Exp.: 01/2027.
• Mar 19, 2026 · Class II · Teva Pharmaceuticals USA, Inc
  CGMP Deviations: use of an unapproved raw material
  Lots: Lot: 100060002, Exp.: 07/2026; 100066802, Exp.: 05/2027
• Mar 19, 2026 · Class II · Teva Pharmaceuticals USA, Inc
  CGMP Deviations: use of an unapproved raw material
  Lots: Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.
• Oct 28, 2021 · Class III · Teva Pharmaceuticals USA
  Failed Impurities/Degradation Specifications
  Lots: Lot# 1369117B, exp. date 11/2021

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Clonidine: every company that makes it

Form

patch, transdermal

Strength

0.3 mg per 1 d

Approval

ANDA ANDA090873

On the market since

May 6, 2014

Package NDCs

0591-3510-04 0591-3510-54

Official label

DailyMed (National Library of Medicine), updated Nov 28, 2023

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?